statistiche ricercatore

SPANEVELLO, ANTONIO

Distribuzione geografica

Continente	#
NA - Nord America	22.955
EU - Europa	10.608
AS - Asia	8.476
SA - Sud America	1.049
Continente sconosciuto - Info sul continente non disponibili	678
AF - Africa	211
OC - Oceania	47
Totale	44.024

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	22.650
IT - Italia	5.225
SG - Singapore	2.729
CN - Cina	2.154
UA - Ucraina	1.554
VN - Vietnam	1.100
HK - Hong Kong	984
BR - Brasile	852
TR - Turchia	689
SE - Svezia	649
GB - Regno Unito	575
IE - Irlanda	550
DE - Germania	465
FI - Finlandia	460
FR - Francia	393
RU - Federazione Russa	302
BD - Bangladesh	300
CA - Canada	124
IN - India	121
MX - Messico	119
NL - Olanda	115
NG - Nigeria	100
AT - Austria	74
AR - Argentina	71
JP - Giappone	70
IQ - Iraq	41
PL - Polonia	39
ID - Indonesia	35
AU - Australia	34
ZA - Sudafrica	31
EC - Ecuador	30
BE - Belgio	29
ES - Italia	28
SA - Arabia Saudita	28
PK - Pakistan	27
CZ - Repubblica Ceca	23
KR - Corea	23
MA - Marocco	22
MY - Malesia	22
VE - Venezuela	21
CO - Colombia	20
CL - Cile	19
CH - Svizzera	18
CR - Costa Rica	17
UZ - Uzbekistan	17
PE - Perù	15
AE - Emirati Arabi Uniti	14
TW - Taiwan	14
RO - Romania	13
NP - Nepal	12
NZ - Nuova Zelanda	12
DZ - Algeria	11
EU - Europa	11
HU - Ungheria	11
KZ - Kazakistan	11
MD - Moldavia	11
TH - Thailandia	11
JO - Giordania	10
LT - Lituania	10
PH - Filippine	10
HN - Honduras	9
KE - Kenya	9
PT - Portogallo	9
PY - Paraguay	9
AL - Albania	8
AZ - Azerbaigian	8
EG - Egitto	8
NO - Norvegia	8
SK - Slovacchia (Repubblica Slovacca)	8
TN - Tunisia	8
BO - Bolivia	7
IR - Iran	7
JM - Giamaica	7
OM - Oman	7
GR - Grecia	6
TT - Trinidad e Tobago	6
BG - Bulgaria	5
DK - Danimarca	5
SN - Senegal	5
BH - Bahrain	4
CI - Costa d'Avorio	4
GT - Guatemala	4
LK - Sri Lanka	4
PA - Panama	4
UY - Uruguay	4
BA - Bosnia-Erzegovina	3
BB - Barbados	3
BY - Bielorussia	3
IL - Israele	3
KH - Cambogia	3
LB - Libano	3
LY - Libia	3
MM - Myanmar	3
GD - Grenada	2
GE - Georgia	2
GN - Guinea	2
HR - Croazia	2
LU - Lussemburgo	2
NI - Nicaragua	2
RS - Serbia	2
Totale	43.326

Salva come PNG Salva come JPEG

Città	#
Milan	3.470
Fairfield	2.338
Ashburn	1.847
Woodbridge	1.831
San Jose	1.682
Singapore	1.463
Jacksonville	1.262
Houston	1.214
Ann Arbor	1.207
Chandler	1.100
Hong Kong	969
Wilmington	931
Seattle	929
Cambridge	788
Council Bluffs	654
Dallas	568
Dublin	533
Princeton	532
Shenzhen	467
Dearborn	410
Boardman	383
The Dalles	381
Izmir	372
Beijing	314
Nyköping	314
Chicago	309
Rome	296
Dong Ket	285
Lauterbourg	284
New York	229
Ho Chi Minh City	190
Santa Clara	186
San Diego	172
London	152
Los Angeles	143
Hanoi	137
Como	126
Helsinki	123
San Mateo	120
Ogden	104
Abuja	95
São Paulo	88
Mexico City	79
Hefei	77
Munich	70
Guangzhou	69
Washington	69
Falls Church	57
Tokyo	57
Kocaeli	49
Shanghai	49
Phoenix	48
Orem	46
Nanjing	44
Columbus	43
Nuremberg	43
San Francisco	43
Frankfurt am Main	41
Toronto	41
Vienna	41
Atlanta	39
Kunming	39
Amsterdam	38
Salt Lake City	38
Norwalk	36
Brooklyn	34
Chennai	34
Buffalo	33
Rio de Janeiro	32
San Genesio Ed Uniti	32
Warsaw	32
Tianjin	30
Verona	30
Hangzhou	27
Philadelphia	27
Jinan	26
Montreal	26
Brussels	24
Tampa	24
Zhengzhou	24
Düsseldorf	23
Redmond	23
Haiphong	22
Redwood City	22
Da Nang	21
Naples	21
Belo Horizonte	19
Dhaka	19
Stockholm	19
Johannesburg	18
Magnago	18
Pavia	18
Chengdu	17
Elk Grove Village	17
Kilburn	17
Manchester	17
Shenyang	17
Baghdad	16
Brno	16
Nanchang	16
Totale	30.965

Salva come PNG Salva come JPEG

Nome	#
Convergent sets of data from in vivo and in vitro methods point to an active role of Hsp60 in chronic obstructive pulmonary disease pathogenesis	596
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases	331
Airway inflammation in patients affected by obstructive sleep apnea	309
The effects of a cognitive behavioural intervention in asthmatic patients.	300
Five-year survival of stage IIIA-IIIB (non-N3) non-small cell lung cancer patients after platinum/gemcitabine induction chemotherapy and surgery	255
Classifying new anti-tuberculosis drugs: rationale and future perspectives	251
Six-Minute Walking Distance Improvement after Pulmonary Rehabilitation Is Associated with Baseline Lung Function in Complex COPD Patients: A Retrospective Study	244
A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis	235
Aging and airway inflammation	233
A European Respiratory Society technical standard: exhaled biomarkers in lung disease	233
Adherence to Continuous Positive Airway Pressure in patients with Obstructive Sleep Apnoea. A ten year real life study	232
Aging and induced-sputum cells	226
Models of respiratory infections: Virus-induced asthma exacerbations and beyond	219
3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer.	218
A new Editorial Board of Monaldi Archives for Chest Disease	217
Brittle Asthma	215
Exhaled pH, exhaled nitric oxide, and induced sputum cellularity in obese patients with obstructive sleep apnea syndrome	215
Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases	215
A pilot study of nurse-led, home monitoring for patients with chronic respiratory failure and with mechanical ventilation assistance	214
Effects of Pulmonary Rehabilitation in Patients with Non-Cystic Fibrosis Bronchiectasis: A Retrospective Analysis of Clinical and Functional Predictors of Efficacy	214
Clinical and operational value of the extensively drug-resistant tuberculosis definition	213
Airway inflammatory phenotypes: Making sputum cell evaluation more accessible for clinical use	213
Therapeutic drug monitoring: How to improve drug dosage and patient safety in tuberculosis treatment	211
Prognostic value of Exhaled Microsatellite alterations at 3p in NSCLC patients.	210
Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation	208
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial	206
Effectiveness of pulmonary rehabilitation in severe asthma: a retrospective data analysis	205
Menopausal asthma: a new biological phenotype?	203
Effectiveness and safety of meropenem/ clavulanate-containing regimens in the treatment of MDR- and XDR-TB	202
Bronchoalveolar lavage causes decrease in PaO2, increase in (A-a) gradient value and bronchoconstriction in asthmatics	201
When kidneys and lungs suffer together	201
Tuberculosis elimination: theory and practice in Europe	199
Markers of airway inflammation in pulmonary diseases assessed by induced sputum.	199
Frequent coexistence of chronic heart failure and chronic obstructive pulmonary disease in respiratory and cardiac outpatients: Evidence from SUSPIRIUM, a multicentre Italian survey	198
Induced sputum to assess airway inflammation: a study of reproducibility	197
Microsatellite alterations suggestive of organ-specific asthma and atopy in exhaled breath condensate	197
Exhaled NO and iNOS expression in sputum cells of healthy, obese and OSA subjects	197
Efficacy of pulmonary rehabilitation in chronic respiratory failure (CRF) due to chronic obstructive pulmonary disease (COPD): The Maugeri Study	196
Ripped from the headlines: how can we harness communications to control TB?	196
Improving the TB case management: The International Standards for Tuberculosis Care	196
Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results	196
Inflammation, oxidative stress and systemic effects in mild chronic obstructive pulmonary disease.	195
Airway responsiveness to methacholine: effects of deep inhalations and airway inflammation.	195
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials	195
Economic analysis of two structured treatment and teaching programs on asthma	194
History of tuberculosis and drug resistance	194
Pulmonary rehabilitation is effective in patients with tuberculosis pulmonary sequelae	194
AIDS and tuberculosis control programmes: an integrated approach at educational level.	193
Prevalence and prevention of venous thromboembolism in patients with acute exacerbations of COPD	193
Bronchial hyperresponsiveness, airway inflammation, and reversibility in patients with chronic obstructive pulmonary disease	193
Exhaled matrix metalloproteinase-9 (MMP-9) in different biological phenotypes of asthma	192
Tele-assistance in Chronic Respiratory Failure Patients: a Randomised Clinical Trial.	191
Estimation of minimal clinically important difference in EQ-5D visual analog scale score after pulmonary rehabilitation in subjects with COPD	191
In vitro susceptibility testing and totally drug-resistant tuberculosis	190
Systemic and airway inflammation in sleep apnea and obesity: the role of ICAM-1 and IL-8	189
European union standards for tuberculosis care	189
Tiotropium and exercise training in COPD patients: effects on dyspnea and exercise tolerance	189
Comparison of effectiveness and safety of imipenem/clavulanate-versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB	189
Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: values in healthy adults	188
An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD	188
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis	188
Induced sputum in children: feasibility, repeatability, and relation of findings to asthma severity	187
Sputum induced cellularity in a group of traffic policemen	187
Effect of methacholine challenge on cellular composition of sputum induction	187
Fibre types in skeletal muscles of chronic obstructive pulmonary disease patients related to respiratory function and exercise tolerance.	187
Effects of intradermal injection of atrial natriuretic peptide.	185
Airway inflammation in patients affected by obstructive sleep apnea syndrome.	185
Validity and reproducibility of morphologic analysis of nasal secretions obtained using ultrasonic nebulization of hypertonic solution	185
Comparison of two methods of processing induced sputum: selected versus entire sputum	184
Airway inflammation in healthy smokers	184
Tuberculosis elimination: Where are we now?	184
Latex allergy and sensitization in cities: a survey in a population at risk	183
Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis?	181
An electronic nose in the discrimination of patients with asthma and controls	181
Heterogeneity of pulmonary rehabilitation: like apples and oranges - both healthy fruit	180
Consensus not yet reached on key drugs for extensively drug-resistant tuberculosis treatment	178
Epidemiology and clinical management of XDR-TB: a systematic review by TBNET	177
Do blood eosinophils strictly reflect airway inflammation in COPD? Comparison with asthmatic patients	177
Chronic bronchial asthma from challenge to treatment: epidemiology and social impact	176
Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis	176
Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells	176
Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma	175
Recent developments in the diagnosis and management of tuberculosis	175
Italian survey on prevalence and disease management of chronic heart failure and chronic obstructive pulmonary disease comorbidity in ambulatory patients. SUSPIRIUM study rationale and design	174
Towards a practical clinical use of fractioned exhaled nitric oxide levels in chronic cough	174
Efficacy and safety of surgical lung biopsy for interstitial disease. Experience of 161 consecutive patients from a single institution in Italy	173
Is bronchodilator the correct treatment for COPD subjects before EBUS?	173
Computerized patient record for a department of respiratory rehabilitation.	172
SPUTUM AND EXHALED BREATH ANALYSIS	172
Development of a Barthel Index based on dyspnea for patients with respiratory diseases	172
The new frontiers of rehabilitation medicine in people with chronic disabling illnesses	172
Assembly 5: Airway diseases	170
Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease	170
Exhaled inflammatory markers in aspirin-induced asthma syndrome	169
Prospects of rehabilitation in respiratory diseases	168
Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease	168
Management of drug resistantTB in patients with HIV co-infection	168
The mechanics of the lung parenchyma and airway responsiveness to metacholine.	167
Changes in sputum composition during 15 min of sputum induction in healthy subjects and patients with asthma and chronic obstructive pulmonary disease	166
Broncopneumopatia Cronica Ostruttiva	166
Totale	20.130

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	193.342
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	193.342

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	2.427	0	328	168	70	83	185	204	176	157	486	221	349
2022/2023	3.395	441	147	291	360	225	701	39	366	452	148	121	104
2023/2024	6.222	840	865	1.323	1.037	1.175	404	101	117	185	94	51	30
2024/2025	4.451	53	93	781	151	180	355	163	271	523	447	319	1.115
2025/2026	10.901	539	566	685	1.167	703	520	2.556	682	1.351	786	694	652
2026/2027	870	398	472	0	0	0	0	0	0	0	0	0	0
Totale													44.024